Stand out for this role — generate a tailored resume and cover letter in about a minute.
Sarah Cannon Research Institute (SCRI), a McKesson subsidiary, seeks a Lead Intelligent Solutions Engineer to design, build, and deploy AI and automation solutions end-to-end. You will own architecture, ensure quality, and deliver value across enterprise workflows using LLMs, agents, and orchestration frameworks.
This senior role requires deep technical skill, strong architectural judgment, and the ability to drive ambitious initiatives in a fully remote US-based setting.
It’s More Than a Career, It’s a Mission. Our people are the foundation of our success. By joining our growing team at Sarah Cannon Research Institute (SCRI), a subsidiary of McKesson, you will have the opportunity to become part of one of the largest community‑based cancer programs to advance oncology treatments and improve outcomes for cancer patients across the globe. We look for mission‑driven candidates who have a desire to advance the fight against cancer and make a difference in the lives of patients diagnosed with cancer every day. Our Mission People who live with cancer – those who work to prevent it, fight it, and survive it – are at the heart of every decision we make. Bringing the most innovative medical minds together with the most passionate caregivers in their communities, we are transforming care and personalizing treatment. Through clinical excellence and cutting‑edge research, SCRI is redefining cancer care around the world. The Lead Intelligent Solutions Engineer is a senior, hands‑on technical builder‑leader accountable for delivering AI and intelligent automation solutions end‑to‑end, from problem framing through production deployment and sustained value realization. This role personally designs, builds, and scales LLM‑ and agent‑based automations while owning solution architecture, technical quality, delivery outcomes, and enterprise standards. This position requires deep technical expertise, strong architectural judgment, and the ability to independently drive complex, ambiguous initiatives to completion. The role is not oversight‑only; it is focused on custom AI development, intelligent automation, and solution execution using large language models, agents, orchestration frameworks, and enterprise integrations. In addition, this role is expected to evangelize and engage the business, translating opportunities and problems into tangible, trusted, production‑ready AI solutions that measurably improve productivity, quality, cycle time, and decision‑making across SCRI. This is a remote position based in the United States. Relocation assistance and visa sponsorship are not available
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community‑based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. In 2022, SCRI formed a joint venture with former US Oncology Research to expand clinical trial access across the country. It has conducted more than 850 first‑in‑human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA in the past decade. SCRI’s research network brings together more than 1,300 physicians who are enrolling patients into clinical trials at more than 200 locations in 20+ states across the U.S. Please click here to learn more about our research offerings. We care about the well‑being of the patients and communities we serve, and that starts with caring for our people. That’s why we have a Total Rewards package that includes comprehensive benefits to support physical, mental, and financial well‑being. Our Total Rewards offerings serve the different needs of our diverse colleague population and ensure they are the healthiest versions of themselves. For more information regarding benefits through our parent company, McKesson, please click here. As part of Total Rewards, we are proud to offer a competitive compensation package. This is determined by several factors, including performance, experience and skills, equity, regular job market evaluations, and geographical markets. In addition to base pay, other compensation, such as an annual bonus or long‑term incentive opportunities may be offered.
We are an equal opportunity employer and value diversity at our company.
We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community‑based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. In 2022, SCRI formed a joint venture with former US Oncology Research to expand clinical trial access across the country. It has conducted more than 850 first‑in‑human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA in the past decade. SCRI’s research network brings together more than 1,300 physicians who are enrolling patients into clinical trials at more than 200 locations in 20+ states across the U.S. Please click here to learn more about our research offerings.
We deliver careers with purpose and potential. Our focus on better health starts with creating an inclusive environment with strong values where you can build a fulfilling career. You can count on us to provide you with resources and opportunities to grow and be your best, while contributing to our pursuit of improving lives. Every day, McKesson’s employees deliver products to healthcare providers that make a difference in the care and life of a patient. We work to distribute medical supplies, bandages, syringes, vials of flu vaccine, and pharmaceutical drugs to help real patients like Jack, an eight‑year‑old boy battling cancer. We take that job seriously. Together, the work we do is shaping the future of healthcare.